Gelteq Ltd (GELS)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Gelteq Ltd (GELS) is up 8.8% since the beginning of the year. At $1 per share, GELS is trading 56.9% below its 52-week high of $2.

Gelteq Ltd (GELS) has returned 8.84% so far this year and -45.58% over the past 12 months.

Based on dividend-adjusted daily data since Oct 29, 2024, GELS's average daily return is +0.61%, while the average monthly return is -2.38%.

Historically, 29% of months were positive and 71% were negative. The best month was Apr 2025 with a return of +102.9%, while the worst month was Mar 2025 at -36.6%. The longest winning streak lasted 1 consecutive months, and the longest losing streak was 4 months.

On a daily basis, GELS closed higher 40% of trading days. The best single day was Apr 22, 2025 with a return of +220.0%, while the worst single day was Dec 12, 2024 at -36.3%.

Gelteq Ltd has an annualized alpha of 206.31%, beta of 2.49, and R2 of 0.02 versus S&P 500 Index. Calculated based on daily prices since October 29, 2024.

• This stock participated in 196.19% of S&P 500 Index downside but only -114.06% of its upside - more exposed to losses than it benefited from rallies.
• R2 of 0.02 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

GELS ranks 40 for risk / return — on par with similar stocks. You're getting a typical balance of risk and reward. Not a standout, but not a red flag either — a reasonable choice if other factors align with your goals.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Gelteq Ltd. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Gelteq Ltd was 91.86%, occurring on May 19, 2026. The portfolio has not yet recovered.

The current Gelteq Ltd drawdown is 81.82%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Gelteq Ltd over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Gelteq Ltd is priced in the market compared to other companies in the Drug Manufacturers - Specialty & Generic industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.